Wells Fargo & Company Pulse Biosciences, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,899 shares of PLSE stock, worth $157,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,899
Previous 8,362 6.42%
Holding current value
$157,334
Previous $93,000 67.74%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$10.83 - $21.83 $5,815 - $11,722
537 Added 6.42%
8,899 $156,000
Q2 2024

Aug 13, 2024
BUY
$6.69 - $14.54 $2,455 - $5,336
367 Added 4.59%
8,362 $93,000
Q1 2024

May 10, 2024
SELL
$7.8 - $11.02 $41,254 - $58,284
-5,289 Reduced 39.81%
7,995 $69,000
Q4 2023

Feb 09, 2024
SELL
$3.85 - $12.84 $6,256 - $20,865
-1,625 Reduced 10.9%
13,284 $162,000
Q3 2023

Nov 13, 2023
SELL
$4.03 - $8.73 $10,026 - $21,720
-2,488 Reduced 14.3%
14,909 $60,000
Q2 2023

Aug 15, 2023
BUY
$3.67 - $8.64 $31,906 - $75,116
8,694 Added 99.9%
17,397 $125,000
Q1 2023

May 12, 2023
SELL
$2.48 - $3.88 $4,583 - $7,170
-1,848 Reduced 17.51%
8,703 $29,000
Q4 2022

Feb 13, 2023
BUY
$1.73 - $2.89 $3,965 - $6,623
2,292 Added 27.75%
10,551 $29,000
Q3 2022

Nov 14, 2022
SELL
$1.23 - $2.3 $293 - $549
-239 Reduced 2.81%
8,259 $19,000
Q2 2022

Aug 12, 2022
SELL
$1.48 - $4.28 $4,506 - $13,032
-3,045 Reduced 26.38%
8,498 $13,000
Q1 2022

May 16, 2022
SELL
$4.21 - $14.79 $43,741 - $153,668
-10,390 Reduced 47.37%
11,543 $56,000
Q4 2021

Feb 14, 2022
BUY
$14.78 - $24.4 $122,348 - $201,983
8,278 Added 60.62%
21,933 $324,000
Q3 2021

Nov 15, 2021
BUY
$17.25 - $26.63 $56,493 - $87,213
3,275 Added 31.55%
13,655 $295,000
Q2 2021

Aug 16, 2021
SELL
$16.31 - $23.64 $419,199 - $607,595
-25,702 Reduced 71.23%
10,380 $170,000
Q1 2021

May 13, 2021
BUY
$22.43 - $44.27 $249,802 - $493,034
11,137 Added 44.65%
36,082 $855,000
Q4 2020

Feb 09, 2021
SELL
$11.66 - $24.5 $25,547 - $53,679
-2,191 Reduced 8.07%
24,945 $595,000
Q3 2020

Nov 05, 2020
SELL
$9.27 - $13.14 $35,216 - $49,918
-3,799 Reduced 12.28%
27,136 $320,000
Q2 2020

Aug 13, 2020
BUY
$6.23 - $13.09 $81,837 - $171,950
13,136 Added 73.8%
30,935 $324,000
Q1 2020

May 14, 2020
BUY
$5.23 - $15.2 $93,088 - $270,544
17,799 New
17,799 $128,000

Others Institutions Holding PLSE

# of Institutions
77
Shares Held
5.41M
Call Options Held
139K
Put Options Held
84.2K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $656M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email